Xeltis

Xeltis is a medtech company developing transformative vascular implants that enable the natural creation of living and long-lasting tissue. They are focused on addressing the limitations of currently available options for the millions of people requiring hemodialysis vascular access or cardiovascular replacements every year. Xeltis leverages its proprietary endogenous tissue restoration (ETR) platform, which uses advanced polymer implants that regenerate the patient's own tissue, ultimately leading to new, living, and long-lasting vessels and valves.

Xeltis is headquartered in Eindhoven, Netherlands, and has clinical operations throughout Europe and the United States. The company is backed by a leading group of international investors, including DaVita Venture Group, EQT Life Sciences, Kurma Partners, VI Partners, and Ysios Capital. Their current focus is on developing medical devices for hemodialysis vascular access, coronary artery bypass surgery, and pulmonary heart valve replacement. Xeltis has a strong pipeline of clinical programs that are showing promising early results, indicating their potential to revolutionize the field of vascular and cardiovascular surgery.

Xeltis is a medical technology company dedicated to developing transformative vascular implants that enable the natural creation of living and long-lasting tissue. Their proprietary Endogenous Tissue Restoration (ETR) platform utilizes advanced polymers that trigger the body's natural healing response to regenerate tissue, creating new, living vessels and valves that replace traditional implants. This innovative approach aims to address the limitations of current options for millions of patients requiring hemodialysis access or cardiovascular replacements.

Xeltis promotes a culture of innovation, respect, and ownership. The company values the contributions of its employees, encouraging them to take initiative and work together towards a common goal. They believe in personal development and fostering a fun and collaborative work environment.

Xeltis embraces diversity, equity and inclusion as core values, recognizing that a diverse workforce fosters innovation, creativity, and a better understanding of patient needs. They actively cultivate an inclusive work environment where individuals from all backgrounds feel valued, respected, and empowered to contribute their unique perspectives. This commitment is reflected in their representation of over 16 nationalities within their international team, headquartered in Eindhoven, Netherlands with clinical operations across Europe and the US.